FDA Approves Selumetinib for Neurofibromatosis Type 1
It is approved for patients who have symptomatic, inoperable plexiform neurofibromas
Oncology News
ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
1549 results
Resource Shortages Raise Critical Ethical Issues in Cancer Care During the Pandemic
With Massimo Di Maio, Mauriziano Hospital, Turin, Italy
Cancer Core Europe Urges To Close Key Knowledge Gaps on COVID-19 in Cancer Patients
Research priorities related to incidence, morbidity and mortality of COVID-19 specific to patients with cancer
FDA Approves Mitomycin for Low Grade Upper Tract Urothelial Cancer
Efficacy of mitomycin for pyelocaliceal use is determined in an ongoing OLYMPUS trial
Pathological Response to Neoadjuvant Immunotherapy in Patients with pMMR and dMMR Early Colon Cancer
Findings from the NICHE study
FDA Approves Encorafenib in Combination with Cetuximab for mCRC with a BRAF V600E Mutation
Evidence for efficacy is based on the results from the BEACON CRC trial
Challenges in Managing Clinical Trials in Oncology in the COVID-19 Era
With Stefan Zimmerman, Lausanne University Hospital, Switzerland
Cumulative Risk Factors for COVID-19 Complications in Patients with Lung Cancer
An accurate COVID-19 screening model could allow early detection and potentially reduce the risk of severe complications and mortality
FDA Approves Luspatercept-aamt for Anaemia in Adults with Myelodysplastic Syndromes
Efficacy was demonstrated in the MEDALIST trial
Protecting Medical Staff to Ensure Cancer Patients Can Safely Receive Care During the Pandemic
With Antonio Passaro, European Institute of Oncology (IEO), Milan, Italy
No Change to Product Information for Lapatinib Following Re-assessment of Data
Outcome of review of breast cancer study data by EMA
Protecting Patients with Cancer Against Severe COVID-19 Disease in France
Guidelines commissioned by the French health authorities